US Stock MarketDetailed Quotes

VYNE VYNE Therapeutics

Watchlist
  • 2.8400
  • -0.0500-1.73%
Trading May 8 15:39 ET
40.04MMarket Cap-1021P/E (TTM)

VYNE Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

VYNE Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

76.00K

+1166.67%
EPS(YoY)

-0.44

+86.82%
Analyst Rating

Buy

Apr 30, 2024

VYNE Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 110.000K--
--2024/Q1-- / 100.000K--
--2023/Q476.000K / 150.000K--
--2023/Q3114.000K / 150.000K--
--2023/Q2135.000K / 50.000K--
--2023/Q199.000K / 0.000--
--2022/Q46.000K / 60.000K--
--2022/Q3167.000K / 50.000K--
--2022/Q2126.000K / 100.000K--
--2022/Q1178.000K / 366.670K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 110.000K--
--2024/Q1-- / 100.000K--
--2023/Q476.000K / 150.000K--
--2023/Q3114.000K / 150.000K--
--2023/Q2135.000K / 50.000K--
--2023/Q199.000K / 0.000--
--2022/Q46.000K / 60.000K--
--2022/Q3167.000K / 50.000K--
--2022/Q2126.000K / 100.000K--
--2022/Q1178.000K / 366.670K--

Unlock Free Earnings Estimates

VYNE Therapeutics Earnings Reports

  • VYNE Therapeutics | 10-K: Annual report

    Mar 1 16:09 ET

  • VYNE Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 07:57 ET

  • VYNE Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 16:02 ET

  • VYNE Therapeutics | 10-Q: Q1 2023 Earnings Report

    May 11, 2023 16:24 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg